Business Context and Reporting Period
Company: Organogenesis Holdings Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 12, 2019
Event: Entry into a Material Definitive Agreement (Warrant Exchange Agreement).
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a corporate transaction regarding warrant exchanges.
Material Changes and Transaction Details
- Agreement: On July 12, 2019, the Company entered into a Warrant Exchange Agreement with Avista Capital Partners IV L.P. and Avista Capital Partners IV (Offshore), L.P. (collectively, "PIPE Investors").
- Transaction Scope: PIPE Investors agreed to exchange 4,100,000 warrants (PIPE Warrants) exercisable for one-half of one share of Class A Common Stock at $5.75 per half share.
- Exchange Ratio: The exchange ratio will match the ratio of the Company's planned Exchange Offer to all holders of Public Warrants issued during the October 10, 2016 IPO.
- Condition Precedent: The exchange is contingent upon the Company accepting a tender of 65% or more of the outstanding Public Warrants in the Exchange Offer.
- Regulatory Status: The exchange is exempt from registration under Section 3(a)(9) of the Securities Act as no commission or remuneration was paid for solicitation.
Guidance, Outlook, and Risks
- Outlook: The Company plans to conduct an Exchange Offer for Public Warrants, details of which will be filed in a Tender Offer Statement on Schedule TO.
- Investor Action: Public Warrant holders are advised to await the definitive proxy statement and related documents (Offer to Exchange Letter, Consent Solicitation) before making decisions.
- Disclaimer: This 8-K is for informational purposes only and does not constitute an offer to purchase or sell securities.
Key Facts for Investor Verification
- Verify the final exchange ratio once the Exchange Offer for Public Warrants is completed.
- Confirm whether the 65% tender threshold for Public Warrants is met to trigger the PIPE Investors' exchange.
- Review the upcoming Tender Offer Statement on Schedule TO for specific terms and risks associated with the Public Warrant exchange.
- Note that this filing does not provide updated financial statements or operational metrics.